Announced Mon, 29 Sept · 19:53 IST

As per attachment.

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Norris Medicines Ltd has submitted the voting results for its 34th Annual General Meeting held on September 29, 2025, for the financial year 2024-2025. The meeting was conducted through video conferencing and lasted about 24 minutes, from 3:30 p.m. to 3:54 p.m. IST. The filing has been made with BSE as required under SEBI's Listing Regulations. The letter is signed by Director Vimal D. Shah. The actual detailed voting results (resolution-wise) would be available in the attached document.

Likely market impact

This is a routine post-AGM compliance filing and is unlikely to have any material impact on the stock price. Investors should check the attached voting results document to see how shareholders voted on key resolutions.